nodes	percent_of_prediction	percent_of_DWPC	metapath
Bleomycin—LIG3—Resolution of AP sites via the single-nucleotide replacement pathway—MUTYH—colon cancer	0.0661	0.138	CbGpPWpGaD
Bleomycin—LIG3—Base Excision Repair—MUTYH—colon cancer	0.0458	0.0959	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair—MSH6—colon cancer	0.0245	0.0513	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair—MSH2—colon cancer	0.0199	0.0416	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—PMS2—colon cancer	0.0196	0.0411	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—PMS2—colon cancer	0.0196	0.0411	CbGpPWpGaD
Bleomycin—LIG1—embryo—colon cancer	0.0195	0.103	CbGeAlD
Bleomycin—LIG1—Removal of DNA patch containing abasic residue—MUTYH—colon cancer	0.0194	0.0407	CbGpPWpGaD
Bleomycin—LIG1—MMR—PMS2—colon cancer	0.0186	0.039	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair—MLH1—colon cancer	0.0179	0.0375	CbGpPWpGaD
Bleomycin—Ichthyosis acquired—Fluorouracil—colon cancer	0.0178	0.0558	CcSEcCtD
Bleomycin—Ichthyosis—Fluorouracil—colon cancer	0.0178	0.0558	CcSEcCtD
Bleomycin—LIG1—Base Excision Repair—MUTYH—colon cancer	0.0178	0.0372	CbGpPWpGaD
Bleomycin—LIG3—epithelium—colon cancer	0.0172	0.0912	CbGeAlD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—MSH6—colon cancer	0.0163	0.0341	CbGpPWpGaD
Bleomycin—LIG3—renal system—colon cancer	0.016	0.0846	CbGeAlD
Bleomycin—LIG1—MMR—MSH6—colon cancer	0.0154	0.0324	CbGpPWpGaD
Bleomycin—Nail changes—Fluorouracil—colon cancer	0.0141	0.0443	CcSEcCtD
Bleomycin—LIG3—lymphoid tissue—colon cancer	0.0133	0.0702	CbGeAlD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—MSH2—colon cancer	0.0132	0.0276	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—MSH2—colon cancer	0.0132	0.0276	CbGpPWpGaD
Bleomycin—LIG1—MMR—MSH2—colon cancer	0.0125	0.0262	CbGpPWpGaD
Bleomycin—LIG1—lymphoid tissue—colon cancer	0.0123	0.065	CbGeAlD
Bleomycin—LIG1—digestive system—colon cancer	0.0121	0.0642	CbGeAlD
Bleomycin—BLMH—renal system—colon cancer	0.0119	0.0632	CbGeAlD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—MLH1—colon cancer	0.0119	0.0249	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—MLH1—colon cancer	0.0119	0.0249	CbGpPWpGaD
Bleomycin—LIG1—MMR—MLH1—colon cancer	0.0113	0.0237	CbGpPWpGaD
Bleomycin—LIG1—bone marrow—colon cancer	0.0112	0.0592	CbGeAlD
Bleomycin—LIG3—DNA Repair—MUTYH—colon cancer	0.011	0.023	CbGpPWpGaD
Bleomycin—LIG1—vagina—colon cancer	0.0107	0.0567	CbGeAlD
Bleomycin—LIG3—DNA Repair—PMS2—colon cancer	0.0101	0.0211	CbGpPWpGaD
Bleomycin—BLMH—lymphoid tissue—colon cancer	0.00991	0.0525	CbGeAlD
Bleomycin—Nail changes—Capecitabine—colon cancer	0.00988	0.031	CcSEcCtD
Bleomycin—LIG3—liver—colon cancer	0.00976	0.0517	CbGeAlD
Bleomycin—Lung fibrosis interstitial—Methotrexate—colon cancer	0.00926	0.029	CcSEcCtD
Bleomycin—BLMH—bone marrow—colon cancer	0.00902	0.0478	CbGeAlD
Bleomycin—BLMH—vagina—colon cancer	0.00864	0.0458	CbGeAlD
Bleomycin—BLMH—Topotecan—Irinotecan—colon cancer	0.00848	0.584	CbGdCrCtD
Bleomycin—LIG3—DNA Repair—MSH6—colon cancer	0.00834	0.0175	CbGpPWpGaD
Bleomycin—LIG3—lymph node—colon cancer	0.00748	0.0396	CbGeAlD
Bleomycin—Nail changes—Methotrexate—colon cancer	0.00736	0.0231	CcSEcCtD
Bleomycin—BLMH—liver—colon cancer	0.00729	0.0386	CbGeAlD
Bleomycin—LIG1—lymph node—colon cancer	0.00692	0.0367	CbGeAlD
Bleomycin—Dry cough—Methotrexate—colon cancer	0.0069	0.0216	CcSEcCtD
Bleomycin—LIG3—DNA Repair—MSH2—colon cancer	0.00676	0.0142	CbGpPWpGaD
Bleomycin—LIG3—DNA Repair—MLH1—colon cancer	0.00609	0.0128	CbGpPWpGaD
Bleomycin—BLMH—lymph node—colon cancer	0.00559	0.0296	CbGeAlD
Bleomycin—Localized exfoliation—Capecitabine—colon cancer	0.00532	0.0167	CcSEcCtD
Bleomycin—Hyperkeratosis—Capecitabine—colon cancer	0.00502	0.0157	CcSEcCtD
Bleomycin—Myelosuppression—Vincristine—colon cancer	0.00469	0.0147	CcSEcCtD
Bleomycin—Lung infiltration—Irinotecan—colon cancer	0.00457	0.0143	CcSEcCtD
Bleomycin—Myelosuppression—Fluorouracil—colon cancer	0.00438	0.0137	CcSEcCtD
Bleomycin—LIG1—DNA Repair—MUTYH—colon cancer	0.00427	0.00894	CbGpPWpGaD
Bleomycin—LIG1—Vindesine—Vincristine—colon cancer	0.00422	0.29	CbGdCrCtD
Bleomycin—LIG1—DNA Repair—PMS2—colon cancer	0.0039	0.00817	CbGpPWpGaD
Bleomycin—Mucosal inflammation—Irinotecan—colon cancer	0.00387	0.0121	CcSEcCtD
Bleomycin—Local reaction—Fluorouracil—colon cancer	0.00371	0.0116	CcSEcCtD
Bleomycin—Febrile neutropenia—Vincristine—colon cancer	0.00366	0.0115	CcSEcCtD
Bleomycin—Febrile neutropenia—Irinotecan—colon cancer	0.00356	0.0112	CcSEcCtD
Bleomycin—Rales—Capecitabine—colon cancer	0.0035	0.011	CcSEcCtD
Bleomycin—Skin hyperpigmentation—Fluorouracil—colon cancer	0.00345	0.0108	CcSEcCtD
Bleomycin—Febrile neutropenia—Fluorouracil—colon cancer	0.00341	0.0107	CcSEcCtD
Bleomycin—Hypomagnesaemia—Irinotecan—colon cancer	0.00337	0.0106	CcSEcCtD
Bleomycin—LIG1—DNA Repair—MSH6—colon cancer	0.00323	0.00677	CbGpPWpGaD
Bleomycin—Nail disorder—Fluorouracil—colon cancer	0.00316	0.00991	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.00288	0.00603	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—MSH2—colon cancer	0.00262	0.00549	CbGpPWpGaD
Bleomycin—Rales—Methotrexate—colon cancer	0.0026	0.00815	CcSEcCtD
Bleomycin—Mucosal inflammation—Capecitabine—colon cancer	0.00259	0.00811	CcSEcCtD
Bleomycin—Extravasation—Vincristine—colon cancer	0.00252	0.0079	CcSEcCtD
Bleomycin—Extravasation—Irinotecan—colon cancer	0.00246	0.00769	CcSEcCtD
Bleomycin—Pulmonary fibrosis—Methotrexate—colon cancer	0.00243	0.0076	CcSEcCtD
Bleomycin—Skin hyperpigmentation—Capecitabine—colon cancer	0.00241	0.00755	CcSEcCtD
Bleomycin—Febrile neutropenia—Capecitabine—colon cancer	0.00238	0.00747	CcSEcCtD
Bleomycin—LIG1—DNA Repair—MLH1—colon cancer	0.00236	0.00495	CbGpPWpGaD
Bleomycin—Extravasation—Fluorouracil—colon cancer	0.00235	0.00737	CcSEcCtD
Bleomycin—Tenderness—Fluorouracil—colon cancer	0.00235	0.00737	CcSEcCtD
Bleomycin—Lung infiltration—Methotrexate—colon cancer	0.00228	0.00713	CcSEcCtD
Bleomycin—Ulcer—Irinotecan—colon cancer	0.00227	0.0071	CcSEcCtD
Bleomycin—Hypomagnesaemia—Capecitabine—colon cancer	0.00226	0.00707	CcSEcCtD
Bleomycin—Nail disorder—Capecitabine—colon cancer	0.00221	0.00693	CcSEcCtD
Bleomycin—Ulcer—Fluorouracil—colon cancer	0.00217	0.0068	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.00196	0.00411	CbGpPWpGaD
Bleomycin—Mucosal inflammation—Methotrexate—colon cancer	0.00193	0.00604	CcSEcCtD
Bleomycin—LIG1—Vinblastine—Vincristine—colon cancer	0.00183	0.126	CbGdCrCtD
Bleomycin—Hyperaesthesia—Capecitabine—colon cancer	0.00183	0.00572	CcSEcCtD
Bleomycin—Skin hyperpigmentation—Methotrexate—colon cancer	0.00179	0.00562	CcSEcCtD
Bleomycin—Febrile neutropenia—Methotrexate—colon cancer	0.00177	0.00556	CcSEcCtD
Bleomycin—Injury—Irinotecan—colon cancer	0.00169	0.0053	CcSEcCtD
Bleomycin—Disorientation—Fluorouracil—colon cancer	0.00167	0.00522	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.00165	0.00346	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—BCL10—colon cancer	0.00165	0.00345	CbGpPWpGaD
Bleomycin—Nail disorder—Methotrexate—colon cancer	0.00165	0.00516	CcSEcCtD
Bleomycin—Cerebrovascular accident—Irinotecan—colon cancer	0.00159	0.00497	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—MLH3—colon cancer	0.00153	0.0032	CbGpPWpGaD
Bleomycin—Ulcer—Capecitabine—colon cancer	0.00152	0.00475	CcSEcCtD
Bleomycin—Interstitial lung disease—Methotrexate—colon cancer	0.00151	0.00473	CcSEcCtD
Bleomycin—Skin exfoliation—Capecitabine—colon cancer	0.00137	0.00429	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.00132	0.00277	CbGpPWpGaD
Bleomycin—Pancytopenia—Vincristine—colon cancer	0.00131	0.00411	CcSEcCtD
Bleomycin—Weight decreased—Vincristine—colon cancer	0.00125	0.00391	CcSEcCtD
Bleomycin—Pneumonia—Vincristine—colon cancer	0.00124	0.00388	CcSEcCtD
Bleomycin—Extravasation—Methotrexate—colon cancer	0.00122	0.00383	CcSEcCtD
Bleomycin—Pancytopenia—Fluorouracil—colon cancer	0.00122	0.00383	CcSEcCtD
Bleomycin—Weight decreased—Irinotecan—colon cancer	0.00122	0.00381	CcSEcCtD
Bleomycin—Acute coronary syndrome—Vincristine—colon cancer	0.00121	0.0038	CcSEcCtD
Bleomycin—Phlebitis—Capecitabine—colon cancer	0.00121	0.00379	CcSEcCtD
Bleomycin—Myocardial infarction—Vincristine—colon cancer	0.00121	0.00378	CcSEcCtD
Bleomycin—Pneumonia—Irinotecan—colon cancer	0.00121	0.00378	CcSEcCtD
Bleomycin—Stomatitis—Vincristine—colon cancer	0.0012	0.00376	CcSEcCtD
Bleomycin—Acute coronary syndrome—Irinotecan—colon cancer	0.00118	0.0037	CcSEcCtD
Bleomycin—Myocardial infarction—Irinotecan—colon cancer	0.00117	0.00368	CcSEcCtD
Bleomycin—Stomatitis—Irinotecan—colon cancer	0.00117	0.00366	CcSEcCtD
Bleomycin—Pneumonia—Fluorouracil—colon cancer	0.00115	0.00362	CcSEcCtD
Bleomycin—Acute coronary syndrome—Fluorouracil—colon cancer	0.00113	0.00355	CcSEcCtD
Bleomycin—Ulcer—Methotrexate—colon cancer	0.00113	0.00354	CcSEcCtD
Bleomycin—Myocardial infarction—Fluorouracil—colon cancer	0.00113	0.00353	CcSEcCtD
Bleomycin—Stomatitis—Fluorouracil—colon cancer	0.00112	0.00351	CcSEcCtD
Bleomycin—Hypoaesthesia—Vincristine—colon cancer	0.0011	0.00344	CcSEcCtD
Bleomycin—Haemoglobin—Irinotecan—colon cancer	0.00108	0.00339	CcSEcCtD
Bleomycin—Haemorrhage—Irinotecan—colon cancer	0.00108	0.00337	CcSEcCtD
Bleomycin—Arthritis—Capecitabine—colon cancer	0.00107	0.00336	CcSEcCtD
Bleomycin—Cerebrovascular accident—Capecitabine—colon cancer	0.00106	0.00333	CcSEcCtD
Bleomycin—Cystitis noninfective—Methotrexate—colon cancer	0.00104	0.00327	CcSEcCtD
Bleomycin—Haemoglobin—Fluorouracil—colon cancer	0.00104	0.00324	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.00103	0.00216	CbGpPWpGaD
Bleomycin—Cystitis—Methotrexate—colon cancer	0.00103	0.00323	CcSEcCtD
Bleomycin—Haemorrhage—Fluorouracil—colon cancer	0.00103	0.00323	CcSEcCtD
Bleomycin—Hypoaesthesia—Fluorouracil—colon cancer	0.00103	0.00321	CcSEcCtD
Bleomycin—Skin exfoliation—Methotrexate—colon cancer	0.00102	0.00319	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.00101	0.00212	CbGpPWpGaD
Bleomycin—Flushing—Irinotecan—colon cancer	0.000998	0.00313	CcSEcCtD
Bleomycin—BLMH—Immune System—BCL10—colon cancer	0.000998	0.00209	CbGpPWpGaD
Bleomycin—Alopecia—Vincristine—colon cancer	0.000976	0.00306	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000976	0.00204	CbGpPWpGaD
Bleomycin—Chills—Irinotecan—colon cancer	0.000965	0.00302	CcSEcCtD
Bleomycin—Bladder pain—Methotrexate—colon cancer	0.000965	0.00302	CcSEcCtD
Bleomycin—Alopecia—Irinotecan—colon cancer	0.000951	0.00298	CcSEcCtD
Bleomycin—Alopecia—Fluorouracil—colon cancer	0.000911	0.00285	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—CD8A—colon cancer	0.000902	0.00189	CbGpPWpGaD
Bleomycin—Erythema—Fluorouracil—colon cancer	0.000897	0.00281	CcSEcCtD
Bleomycin—Anaemia—Vincristine—colon cancer	0.000889	0.00278	CcSEcCtD
Bleomycin—Bronchospasm—Capecitabine—colon cancer	0.000885	0.00277	CcSEcCtD
Bleomycin—Ill-defined disorder—Irinotecan—colon cancer	0.000869	0.00272	CcSEcCtD
Bleomycin—LIG1—Disease—CHST5—colon cancer	0.000867	0.00181	CbGpPWpGaD
Bleomycin—LIG1—Disease—LGR5—colon cancer	0.000867	0.00181	CbGpPWpGaD
Bleomycin—Anaemia—Irinotecan—colon cancer	0.000866	0.00271	CcSEcCtD
Bleomycin—Leukopenia—Vincristine—colon cancer	0.000861	0.0027	CcSEcCtD
Bleomycin—LIG1—Synthesis of DNA—CDKN1A—colon cancer	0.000855	0.00179	CbGpPWpGaD
Bleomycin—Pancytopenia—Capecitabine—colon cancer	0.000854	0.00268	CcSEcCtD
Bleomycin—Malaise—Irinotecan—colon cancer	0.000845	0.00265	CcSEcCtD
Bleomycin—Leukopenia—Irinotecan—colon cancer	0.000838	0.00263	CcSEcCtD
Bleomycin—Anaemia—Fluorouracil—colon cancer	0.000829	0.0026	CcSEcCtD
Bleomycin—Myalgia—Vincristine—colon cancer	0.000819	0.00257	CcSEcCtD
Bleomycin—Cough—Irinotecan—colon cancer	0.000817	0.00256	CcSEcCtD
Bleomycin—Weight decreased—Capecitabine—colon cancer	0.000814	0.00255	CcSEcCtD
Bleomycin—Pneumonia—Capecitabine—colon cancer	0.000807	0.00253	CcSEcCtD
Bleomycin—Leukopenia—Fluorouracil—colon cancer	0.000803	0.00252	CcSEcCtD
Bleomycin—LIG1—DNA Replication—CDKN1A—colon cancer	0.000802	0.00168	CbGpPWpGaD
Bleomycin—Acute coronary syndrome—Capecitabine—colon cancer	0.000791	0.00248	CcSEcCtD
Bleomycin—Cerebrovascular accident—Methotrexate—colon cancer	0.000791	0.00248	CcSEcCtD
Bleomycin—Discomfort—Irinotecan—colon cancer	0.000788	0.00247	CcSEcCtD
Bleomycin—Myocardial infarction—Capecitabine—colon cancer	0.000786	0.00246	CcSEcCtD
Bleomycin—Anaphylactic shock—Vincristine—colon cancer	0.000785	0.00246	CcSEcCtD
Bleomycin—Oedema—Vincristine—colon cancer	0.000785	0.00246	CcSEcCtD
Bleomycin—Stomatitis—Capecitabine—colon cancer	0.000782	0.00245	CcSEcCtD
Bleomycin—Infection—Vincristine—colon cancer	0.00078	0.00244	CcSEcCtD
Bleomycin—Confusional state—Irinotecan—colon cancer	0.000771	0.00241	CcSEcCtD
Bleomycin—Thrombocytopenia—Vincristine—colon cancer	0.000768	0.00241	CcSEcCtD
Bleomycin—Haematuria—Capecitabine—colon cancer	0.000765	0.0024	CcSEcCtD
Bleomycin—Oedema—Irinotecan—colon cancer	0.000764	0.00239	CcSEcCtD
Bleomycin—Anaphylactic shock—Irinotecan—colon cancer	0.000764	0.00239	CcSEcCtD
Bleomycin—Myalgia—Fluorouracil—colon cancer	0.000764	0.00239	CcSEcCtD
Bleomycin—Chest pain—Fluorouracil—colon cancer	0.000764	0.00239	CcSEcCtD
Bleomycin—Infection—Irinotecan—colon cancer	0.000759	0.00238	CcSEcCtD
Bleomycin—Discomfort—Fluorouracil—colon cancer	0.000755	0.00236	CcSEcCtD
Bleomycin—Thrombocytopenia—Irinotecan—colon cancer	0.000748	0.00234	CcSEcCtD
Bleomycin—Anorexia—Vincristine—colon cancer	0.000748	0.00234	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000743	0.00156	CbGpPWpGaD
Bleomycin—Confusional state—Fluorouracil—colon cancer	0.000738	0.00231	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—FGFR3—colon cancer	0.000738	0.00154	CbGpPWpGaD
Bleomycin—Hypotension—Vincristine—colon cancer	0.000733	0.0023	CcSEcCtD
Bleomycin—Anaphylactic shock—Fluorouracil—colon cancer	0.000732	0.00229	CcSEcCtD
Bleomycin—Oedema—Fluorouracil—colon cancer	0.000732	0.00229	CcSEcCtD
Bleomycin—Anorexia—Irinotecan—colon cancer	0.000729	0.00228	CcSEcCtD
Bleomycin—Infection—Fluorouracil—colon cancer	0.000727	0.00228	CcSEcCtD
Bleomycin—LIG1—S Phase—CCND1—colon cancer	0.000725	0.00152	CbGpPWpGaD
Bleomycin—Haemoglobin—Capecitabine—colon cancer	0.000724	0.00227	CcSEcCtD
Bleomycin—Haemorrhage—Capecitabine—colon cancer	0.00072	0.00226	CcSEcCtD
Bleomycin—Thrombocytopenia—Fluorouracil—colon cancer	0.000717	0.00225	CcSEcCtD
Bleomycin—Hypoaesthesia—Capecitabine—colon cancer	0.000716	0.00224	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000715	0.00224	CcSEcCtD
Bleomycin—Hypotension—Irinotecan—colon cancer	0.000714	0.00224	CcSEcCtD
Bleomycin—Paraesthesia—Vincristine—colon cancer	0.000705	0.00221	CcSEcCtD
Bleomycin—LIG1—S Phase—CDKN1A—colon cancer	0.000702	0.00147	CbGpPWpGaD
Bleomycin—Anorexia—Fluorouracil—colon cancer	0.000698	0.00219	CcSEcCtD
Bleomycin—Paraesthesia—Irinotecan—colon cancer	0.000686	0.00215	CcSEcCtD
Bleomycin—Hypotension—Fluorouracil—colon cancer	0.000684	0.00214	CcSEcCtD
Bleomycin—Decreased appetite—Vincristine—colon cancer	0.000682	0.00214	CcSEcCtD
Bleomycin—Dyspnoea—Irinotecan—colon cancer	0.000681	0.00214	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—MLH1—colon cancer	0.000673	0.00141	CbGpPWpGaD
Bleomycin—Pain—Vincristine—colon cancer	0.000671	0.0021	CcSEcCtD
Bleomycin—Flushing—Capecitabine—colon cancer	0.000668	0.00209	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000667	0.00209	CcSEcCtD
Bleomycin—Decreased appetite—Irinotecan—colon cancer	0.000664	0.00208	CcSEcCtD
Bleomycin—Paraesthesia—Fluorouracil—colon cancer	0.000657	0.00206	CcSEcCtD
Bleomycin—Pain—Irinotecan—colon cancer	0.000654	0.00205	CcSEcCtD
Bleomycin—Dyspnoea—Fluorouracil—colon cancer	0.000653	0.00204	CcSEcCtD
Bleomycin—Chills—Capecitabine—colon cancer	0.000646	0.00202	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—BUB1B—colon cancer	0.00064	0.00134	CbGpPWpGaD
Bleomycin—Decreased appetite—Fluorouracil—colon cancer	0.000636	0.00199	CcSEcCtD
Bleomycin—Alopecia—Capecitabine—colon cancer	0.000636	0.00199	CcSEcCtD
Bleomycin—Pancytopenia—Methotrexate—colon cancer	0.000636	0.00199	CcSEcCtD
Bleomycin—Feeling abnormal—Irinotecan—colon cancer	0.00063	0.00197	CcSEcCtD
Bleomycin—Erythema—Capecitabine—colon cancer	0.000627	0.00196	CcSEcCtD
Bleomycin—Pain—Fluorouracil—colon cancer	0.000626	0.00196	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—CDH1—colon cancer	0.000623	0.00131	CbGpPWpGaD
Bleomycin—LIG1—Disease—AXIN2—colon cancer	0.000623	0.0013	CbGpPWpGaD
Bleomycin—Body temperature increased—Vincristine—colon cancer	0.00062	0.00194	CcSEcCtD
Bleomycin—Body temperature increased—Irinotecan—colon cancer	0.000604	0.00189	CcSEcCtD
Bleomycin—Feeling abnormal—Fluorouracil—colon cancer	0.000603	0.00189	CcSEcCtD
Bleomycin—Pneumonia—Methotrexate—colon cancer	0.000601	0.00188	CcSEcCtD
Bleomycin—Stomatitis—Methotrexate—colon cancer	0.000582	0.00182	CcSEcCtD
Bleomycin—LIG1—S Phase—MYC—colon cancer	0.000582	0.00122	CbGpPWpGaD
Bleomycin—Ill-defined disorder—Capecitabine—colon cancer	0.000582	0.00182	CcSEcCtD
Bleomycin—Urticaria—Fluorouracil—colon cancer	0.000582	0.00182	CcSEcCtD
Bleomycin—Anaemia—Capecitabine—colon cancer	0.000579	0.00182	CcSEcCtD
Bleomycin—Body temperature increased—Fluorouracil—colon cancer	0.000579	0.00181	CcSEcCtD
Bleomycin—Hypersensitivity—Vincristine—colon cancer	0.000578	0.00181	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—BUB1B—colon cancer	0.000572	0.0012	CbGpPWpGaD
Bleomycin—Haematuria—Methotrexate—colon cancer	0.000569	0.00178	CcSEcCtD
Bleomycin—Malaise—Capecitabine—colon cancer	0.000565	0.00177	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000564	0.00118	CbGpPWpGaD
Bleomycin—Hypersensitivity—Irinotecan—colon cancer	0.000563	0.00176	CcSEcCtD
Bleomycin—Asthenia—Vincristine—colon cancer	0.000563	0.00176	CcSEcCtD
Bleomycin—Leukopenia—Capecitabine—colon cancer	0.000561	0.00176	CcSEcCtD
Bleomycin—Asthenia—Irinotecan—colon cancer	0.000548	0.00172	CcSEcCtD
Bleomycin—BLMH—Immune System—CD8A—colon cancer	0.000547	0.00115	CbGpPWpGaD
Bleomycin—Cough—Capecitabine—colon cancer	0.000547	0.00171	CcSEcCtD
Bleomycin—Hypersensitivity—Fluorouracil—colon cancer	0.000539	0.00169	CcSEcCtD
Bleomycin—Haemoglobin—Methotrexate—colon cancer	0.000539	0.00169	CcSEcCtD
Bleomycin—Haemorrhage—Methotrexate—colon cancer	0.000536	0.00168	CcSEcCtD
Bleomycin—Myalgia—Capecitabine—colon cancer	0.000534	0.00167	CcSEcCtD
Bleomycin—Chest pain—Capecitabine—colon cancer	0.000534	0.00167	CcSEcCtD
Bleomycin—Discomfort—Capecitabine—colon cancer	0.000527	0.00165	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000524	0.0011	CbGpPWpGaD
Bleomycin—Pruritus—Fluorouracil—colon cancer	0.000518	0.00162	CcSEcCtD
Bleomycin—Confusional state—Capecitabine—colon cancer	0.000516	0.00162	CcSEcCtD
Bleomycin—Oedema—Capecitabine—colon cancer	0.000512	0.0016	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.00051	0.00107	CbGpPWpGaD
Bleomycin—Infection—Capecitabine—colon cancer	0.000508	0.00159	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000505	0.00106	CbGpPWpGaD
Bleomycin—Thrombocytopenia—Capecitabine—colon cancer	0.000501	0.00157	CcSEcCtD
Bleomycin—Vomiting—Vincristine—colon cancer	0.000499	0.00156	CcSEcCtD
Bleomycin—Rash—Vincristine—colon cancer	0.000495	0.00155	CcSEcCtD
Bleomycin—Dermatitis—Vincristine—colon cancer	0.000494	0.00155	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000493	0.00103	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—TYMS—colon cancer	0.00049	0.00103	CbGpPWpGaD
Bleomycin—Anorexia—Capecitabine—colon cancer	0.000488	0.00153	CcSEcCtD
Bleomycin—Vomiting—Irinotecan—colon cancer	0.000486	0.00152	CcSEcCtD
Bleomycin—Rash—Irinotecan—colon cancer	0.000482	0.00151	CcSEcCtD
Bleomycin—Dermatitis—Irinotecan—colon cancer	0.000481	0.00151	CcSEcCtD
Bleomycin—Chills—Methotrexate—colon cancer	0.000481	0.00151	CcSEcCtD
Bleomycin—Hypotension—Capecitabine—colon cancer	0.000478	0.0015	CcSEcCtD
Bleomycin—Alopecia—Methotrexate—colon cancer	0.000474	0.00148	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000469	0.000983	CbGpPWpGaD
Bleomycin—BLMH—Immune System—BCL2L1—colon cancer	0.000468	0.00098	CbGpPWpGaD
Bleomycin—Erythema—Methotrexate—colon cancer	0.000467	0.00146	CcSEcCtD
Bleomycin—Nausea—Vincristine—colon cancer	0.000466	0.00146	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000466	0.00146	CcSEcCtD
Bleomycin—Vomiting—Fluorouracil—colon cancer	0.000465	0.00146	CcSEcCtD
Bleomycin—Rash—Fluorouracil—colon cancer	0.000462	0.00145	CcSEcCtD
Bleomycin—Dermatitis—Fluorouracil—colon cancer	0.000461	0.00144	CcSEcCtD
Bleomycin—Paraesthesia—Capecitabine—colon cancer	0.000459	0.00144	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000457	0.000956	CbGpPWpGaD
Bleomycin—Dyspnoea—Capecitabine—colon cancer	0.000456	0.00143	CcSEcCtD
Bleomycin—Nausea—Irinotecan—colon cancer	0.000454	0.00142	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—CDKN1A—colon cancer	0.000449	0.000941	CbGpPWpGaD
Bleomycin—BLMH—Immune System—FGFR3—colon cancer	0.000447	0.000937	CbGpPWpGaD
Bleomycin—Decreased appetite—Capecitabine—colon cancer	0.000445	0.00139	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000445	0.000931	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—TYMS—colon cancer	0.000438	0.000918	CbGpPWpGaD
Bleomycin—Pain—Capecitabine—colon cancer	0.000437	0.00137	CcSEcCtD
Bleomycin—Nausea—Fluorouracil—colon cancer	0.000435	0.00136	CcSEcCtD
Bleomycin—Ill-defined disorder—Methotrexate—colon cancer	0.000433	0.00136	CcSEcCtD
Bleomycin—Anaemia—Methotrexate—colon cancer	0.000431	0.00135	CcSEcCtD
Bleomycin—Feeling abnormal—Capecitabine—colon cancer	0.000422	0.00132	CcSEcCtD
Bleomycin—Malaise—Methotrexate—colon cancer	0.000421	0.00132	CcSEcCtD
Bleomycin—Leukopenia—Methotrexate—colon cancer	0.000418	0.00131	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—SRC—colon cancer	0.000416	0.000871	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000409	0.000857	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000408	0.000855	CbGpPWpGaD
Bleomycin—Cough—Methotrexate—colon cancer	0.000407	0.00128	CcSEcCtD
Bleomycin—Urticaria—Capecitabine—colon cancer	0.000406	0.00127	CcSEcCtD
Bleomycin—Body temperature increased—Capecitabine—colon cancer	0.000404	0.00127	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.0004	0.000838	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—NRAS—colon cancer	0.0004	0.000838	CbGpPWpGaD
Bleomycin—Chest pain—Methotrexate—colon cancer	0.000397	0.00124	CcSEcCtD
Bleomycin—Myalgia—Methotrexate—colon cancer	0.000397	0.00124	CcSEcCtD
Bleomycin—Discomfort—Methotrexate—colon cancer	0.000392	0.00123	CcSEcCtD
Bleomycin—Confusional state—Methotrexate—colon cancer	0.000384	0.0012	CcSEcCtD
Bleomycin—Anaphylactic shock—Methotrexate—colon cancer	0.000381	0.00119	CcSEcCtD
Bleomycin—Infection—Methotrexate—colon cancer	0.000378	0.00119	CcSEcCtD
Bleomycin—BLMH—Immune System—CDH1—colon cancer	0.000378	0.000792	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000378	0.000792	CbGpPWpGaD
Bleomycin—Hypersensitivity—Capecitabine—colon cancer	0.000377	0.00118	CcSEcCtD
Bleomycin—Thrombocytopenia—Methotrexate—colon cancer	0.000373	0.00117	CcSEcCtD
Bleomycin—Asthenia—Capecitabine—colon cancer	0.000367	0.00115	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—EGFR—colon cancer	0.000365	0.000763	CbGpPWpGaD
Bleomycin—Anorexia—Methotrexate—colon cancer	0.000363	0.00114	CcSEcCtD
Bleomycin—Pruritus—Capecitabine—colon cancer	0.000362	0.00113	CcSEcCtD
Bleomycin—Hypotension—Methotrexate—colon cancer	0.000356	0.00111	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000347	0.000727	CbGpPWpGaD
Bleomycin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000347	0.00109	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—KRAS—colon cancer	0.000344	0.000721	CbGpPWpGaD
Bleomycin—Paraesthesia—Methotrexate—colon cancer	0.000342	0.00107	CcSEcCtD
Bleomycin—Dyspnoea—Methotrexate—colon cancer	0.00034	0.00106	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000336	0.000703	CbGpPWpGaD
Bleomycin—Decreased appetite—Methotrexate—colon cancer	0.000331	0.00104	CcSEcCtD
Bleomycin—Pain—Methotrexate—colon cancer	0.000326	0.00102	CcSEcCtD
Bleomycin—Vomiting—Capecitabine—colon cancer	0.000325	0.00102	CcSEcCtD
Bleomycin—Rash—Capecitabine—colon cancer	0.000323	0.00101	CcSEcCtD
Bleomycin—Dermatitis—Capecitabine—colon cancer	0.000322	0.00101	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—PIK3CA—colon cancer	0.000316	0.000662	CbGpPWpGaD
Bleomycin—Feeling abnormal—Methotrexate—colon cancer	0.000314	0.000983	CcSEcCtD
Bleomycin—Nausea—Capecitabine—colon cancer	0.000304	0.000952	CcSEcCtD
Bleomycin—Urticaria—Methotrexate—colon cancer	0.000303	0.000948	CcSEcCtD
Bleomycin—Body temperature increased—Methotrexate—colon cancer	0.000301	0.000943	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—HRAS—colon cancer	0.000293	0.000613	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000284	0.000594	CbGpPWpGaD
Bleomycin—Hypersensitivity—Methotrexate—colon cancer	0.000281	0.000879	CcSEcCtD
Bleomycin—BLMH—Immune System—CTNNB1—colon cancer	0.000279	0.000584	CbGpPWpGaD
Bleomycin—Asthenia—Methotrexate—colon cancer	0.000273	0.000856	CcSEcCtD
Bleomycin—BLMH—Immune System—CDKN1A—colon cancer	0.000273	0.000571	CbGpPWpGaD
Bleomycin—Pruritus—Methotrexate—colon cancer	0.000269	0.000844	CcSEcCtD
Bleomycin—BLMH—Immune System—EP300—colon cancer	0.000259	0.000543	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—AKT1—colon cancer	0.000258	0.000541	CbGpPWpGaD
Bleomycin—BLMH—Immune System—SRC—colon cancer	0.000252	0.000528	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—CCND1—colon cancer	0.000247	0.000517	CbGpPWpGaD
Bleomycin—BLMH—Immune System—NRAS—colon cancer	0.000243	0.000508	CbGpPWpGaD
Bleomycin—Vomiting—Methotrexate—colon cancer	0.000242	0.000759	CcSEcCtD
Bleomycin—Rash—Methotrexate—colon cancer	0.00024	0.000752	CcSEcCtD
Bleomycin—Dermatitis—Methotrexate—colon cancer	0.00024	0.000752	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDKN1A—colon cancer	0.000239	0.0005	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—EP300—colon cancer	0.000227	0.000476	CbGpPWpGaD
Bleomycin—Nausea—Methotrexate—colon cancer	0.000226	0.000709	CcSEcCtD
Bleomycin—BLMH—Immune System—EGFR—colon cancer	0.000221	0.000463	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CCND1—colon cancer	0.000221	0.000462	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CDKN1A—colon cancer	0.000214	0.000447	CbGpPWpGaD
Bleomycin—BLMH—Immune System—KRAS—colon cancer	0.000209	0.000437	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—EP300—colon cancer	0.000203	0.000426	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—MYC—colon cancer	0.000198	0.000415	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PIK3CA—colon cancer	0.000192	0.000402	CbGpPWpGaD
Bleomycin—LIG1—Disease—FGFR3—colon cancer	0.00018	0.000377	CbGpPWpGaD
Bleomycin—BLMH—Immune System—HRAS—colon cancer	0.000178	0.000372	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—MYC—colon cancer	0.000177	0.000371	CbGpPWpGaD
Bleomycin—LIG1—Disease—APC—colon cancer	0.000165	0.000346	CbGpPWpGaD
Bleomycin—BLMH—Immune System—AKT1—colon cancer	0.000157	0.000328	CbGpPWpGaD
Bleomycin—LIG1—Disease—BRAF—colon cancer	0.000155	0.000325	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—TP53—colon cancer	0.000145	0.000305	CbGpPWpGaD
Bleomycin—LIG1—Disease—PTGS2—colon cancer	0.000125	0.000262	CbGpPWpGaD
Bleomycin—LIG1—Disease—CTNNB1—colon cancer	0.000112	0.000235	CbGpPWpGaD
Bleomycin—LIG1—Disease—CDKN1A—colon cancer	0.00011	0.000229	CbGpPWpGaD
Bleomycin—LIG1—Disease—EP300—colon cancer	0.000104	0.000218	CbGpPWpGaD
Bleomycin—LIG1—Disease—SRC—colon cancer	0.000101	0.000212	CbGpPWpGaD
Bleomycin—LIG1—Disease—NRAS—colon cancer	9.75e-05	0.000204	CbGpPWpGaD
Bleomycin—LIG1—Disease—MYC—colon cancer	9.08e-05	0.00019	CbGpPWpGaD
Bleomycin—LIG1—Disease—TGFB1—colon cancer	9.06e-05	0.00019	CbGpPWpGaD
Bleomycin—LIG1—Disease—EGFR—colon cancer	8.88e-05	0.000186	CbGpPWpGaD
Bleomycin—LIG1—Disease—KRAS—colon cancer	8.39e-05	0.000176	CbGpPWpGaD
Bleomycin—LIG1—Disease—PIK3CA—colon cancer	7.71e-05	0.000161	CbGpPWpGaD
Bleomycin—LIG1—Disease—HRAS—colon cancer	7.13e-05	0.000149	CbGpPWpGaD
Bleomycin—LIG1—Disease—AKT1—colon cancer	6.3e-05	0.000132	CbGpPWpGaD
